Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut AllergyMatthew Greenhawt, Paul Turner, Deborah Albright et al.|New England Journal of Medicine|2023Cited by 129
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On StudyBrian P. Vickery, Dareen Siri, Andrea Vereda et al.|The Journal of Allergy and Clinical Immunology In Practice|2020Cited by 89
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEMatthew Greenhawt, Christian Vogelberg, Deborah Albright et al.|The Journal of Allergy and Clinical Immunology In Practice|2025Cited by 14